tiprankstipranks
Trending News
More News >
PharmX Technologies Limited (AU:PHX)
ASX:PHX
Australian Market
Advertisement

PharmX Technologies (PHX) Income Statement

Compare
1 Followers

PharmX Technologies Income Statement

Last quarter (Q4 2022), PharmX Technologies's total revenue was $―, a decrease of ― from previous quarter. In Q4, PharmX Technologies's net income was $―. See PharmX Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22Jun 21Jun 20Jun 19
Total Revenue
$ ―$ ―$ ―$ ―
Gross Profit
$ 10.52M$ 10.77M$ 7.91M$ 8.99M
Operating Expenses
$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 2.17M$ 1.83M$ 801.00K$ 410.00K
EBITDA
$ 2.54M$ 3.32M$ 1.31M$ -125.00K
Operating Income
$ 340.00K$ -914.00K$ -1.33M$ -535.00K
Other Income/Expenses
$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―
Net Income
$ 252.00K$ 1.09M$ 176.00K$ -4.21M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

PharmX Technologies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis